PREVARE U LANCU OPSKRBE U FARMACEUTSKOJ INDUSTRIJI

undergraduate thesis

• Title (english): SUPPLY CHAIN FRAUDS IN PHARMACEUTICAL INDUSTRY
• Author: Jasmina Obradović Kuridža
• Mentor: Sanda Soucie (mentor)
• Granter: University of Zagreb; Faculty of Economics and Business; (Department of Trade and International Business); Zagreb
• Defense date and country: 2022-09-30, Croatia
• Scientific / art field, discipline and subdiscipline: SOCIAL SCIENCES; Economics; International Economics

Abstract

Tržišta diljem svijeta bilježe porast krivotvorenih proizvoda. Posljedice ulaska takvih proizvoda u legalan lanac opskrbe su ozbiljne, ali društvo ih tek od nedavno počinje razotkrivati i istraživati. Posebice su opasne krivotvorine lijekova i medicinskih proizvoda. Geografski razmjer, kao i šteta, koju takvi proizvodi nanose cijeloj svjetskoj populaciji su teško mjerljivi i još se teže mogu otkriti.
Na tržište dolaze različiti oblici farmaceutskih krivotvorina, počevši od proizvoda koji uopće ne sadrže aktivan farmaceutski sastojak pa sve do proizvoda koji sadrže krive ili u potpunosti neaktivne molekule. Uzroci su brojni, a među njima su laka zarada krivotvoritelja, nedostaci zakonodavstva, izuzetno visoki troškovi liječenja, komplicirani uvozni lanac, česte nestašice lijekova te politička nestabilnost i korupcija. Teško je doći do podataka koliko krivotvorenih lijekova zaista uđe u legalno svjetsko tržište jer se samo mali udio takvih slučajeva identificira, prijavi i istraži.

Abstract (english)

Markets around the world are seeing an increase in counterfeit products. The consequences of such products entering the legal supply chain are serious, but society has only recently begun to expose and investigate them. Counterfeit medicines and medical products are especially dangerous. The geographical scale, as well as the damage, that such products inflict on the entire world population are difficult to measure and even more difficult to detect.
Different forms of pharmaceutical counterfeits are coming to the market, starting from products that do not contain active pharmaceutical ingredients at all to products that contain incorrect or completely inactive molecules. The causes are numerous, and among them are the easy earnings of counterfeiters, deficiencies in legislation, extremely high costs of treatment, a complicated import chain, frequent drug shortages, and political instability and corruption. Data on how many counterfeit medicines actually enter the legal world market are difficult to come by because only a small proportion of such cases are identified, reported and investigated.

• Keywords: farmaceutska industrija; krivotvoreni proizvod; krivotvoreni lijek; prevara; lanac opskrbe
• Keywords (english): pharmaceutical industry; counterfeit drug; fraud; supply chain
• Language: croatian
• URN:NBN: urn:nbn:hr:148:977307
• Study programme: Title: Business Economics; Study programme type: professional; Study level: undergraduate; Academic / professional title: stručni/a pristupnik/pristupnica ekonomije (stručni/a pristupnik/pristupnica ekonomije)
• Type of resource: Text
• File origin: Born digital
• Access conditions: Access restricted to students and staff of home institution
• Created on: 2022-10-03 18:39:28